Estimation of a treatment policy estimand for time to event data using data collected post discontinuation of randomised treatment

PHARMACEUTICAL STATISTICS(2022)

Cited 0|Views13
No score
Abstract
Discontinuation from randomised treatment is a common intercurrent event in clinical trials. When the target estimand uses a treatment policy strategy to deal with this intercurrent event, data after cessation of treatment is relevant to estimate the estimand and all efforts should be made to collect such data. Missing data may nevertheless occur due to participants withdrawing from the study and assumptions regarding the values for data that are missing are required for estimation. A missing-at-random assumption is commonly made in this setting, but it may not always be viewed as appropriate. Another potential approach is to assume missing values are similar to data collected after treatment discontinuation. This idea has been previously proposed in the context of recurrent event data. Here we extend this approach to time-to-event outcomes using the hazard function. We propose imputation models that allow for different hazard rates before and after treatment discontinuation and use the posttreatment discontinuation hazard to impute events for participants with missing follow-up periods due to study withdrawal. The imputation models are fitted as Andersen-Gill models. We illustrate the proposed methods with an example of a clinical trial in patients with chronic obstructive pulmonary disease.
More
Translated text
Key words
estimands, missing data, multiple imputation, time to event, treatment policy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined